Exelixis, Inc. (EXEL)
42.86
-0.08
(-0.19%)
USD |
NASDAQ |
Feb 12, 14:28
Exelixis Market Cap : 11.13B for Feb. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Natera, Inc. | 28.58B |
| Merck & Co., Inc. | 298.34B |
| Gilead Sciences, Inc. | 189.48B |
| ADMA Biologics, Inc. | 3.734B |
| Axsome Therapeutics, Inc. | 9.243B |
Market Cap Related Metrics
| PE Ratio | 15.40 |
| PS Ratio | 5.207 |
| PEG Ratio | 0.2698 |
| Price to Book Value | 5.150 |
| Price to Free Cash Flow | 13.79 |
| Price | 42.86 |
| Earnings Yield | 6.50% |
| PEGY Ratio | 0.2698 |
| Operating PE Ratio | 13.53 |
| Normalized PE Ratio | 15.12 |